A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Testing Trends-dtet
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…
Annual Self-Screening With FIT Effective for Colorectal Cancer Detection
...
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
PSA Testing Patterns Vary By Medical Specialty
From - Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
Testing Trends to Watch for in 2016
...
Already a member? Log in here
PCT Effective to ID Invasive Bacterial Infection in Febrile Infants
...
Already a member? Log in here
Simple Patient Info Sheet Not Enough to Dissuade Low-Value Screening
From - Diagnostic Testing & Emerging Technologies
Simple, brief, information sheets are unlikely to change patients' intentions to participate in low-value screenings, according to a study published online…